Loading company…
TARGET PharmaSolutions builds disease registries and analytics for real-world healthcare evidence.
TARGET PharmaSolutions creates longitudinal disease registries in liver disease, gastroenterology, and dermatology, combining patient and clinician outcomes with biosamples. Founded in 2015 and based in Durham, US, it raised USD 2.00 mn in Series A funding led by Rex Health Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in